[Federal Register Volume 85, Number 97 (Tuesday, May 19, 2020)]
[Notices]
[Page 29976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10739]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical CBRN Defense Consortium
Notice is hereby given that, on April 30, 2020, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Attorney General and the Federal
Trade Commission (``MCDC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically 7 Hills Pharma LLC; Houston, TX; Arisan
Therapeutics; San Diego, CA; Biostealth, Inc.; Durham, NC; Bluejay
Diagnostics, Inc.; Acton, MA; Chenega Reliable Services, LLC; San
Antonio, TX; Claremont BioSolutions, Inc.; Upland, CA; Cleveland
Diagnostics, Inc.; Cleveland, OH; CytoDel, Inc.; New York, NY; Data
Intelligence Technologies, Inc; Arlington, VA; Darwin Biosciences,
Inc.; Lyons, CO; DC Photonics, LLC; Dallas, TX; Decisive Point, LLC;
Alexandria, VA; DEFTEC Corporation; Huntsville, AL; DNA TwoPointO Inc.
dba ATUM; Newark, CA; Equivital, Inc.; New York, NY; Grifols Shared
Services NA, Inc.; Los Angeles, CA; HDT Bio Corporation; Seattle, WA;
Heat Biologics; Morrisville, NC; Interlog Corporation; Anaheim, CA;
Koniku, Inc.; San Rafael, CA; Kytopen Corporation; Cambridge, MA; LDS
Technology Consultants, Inc.; Warwick, PA; Lexem Strategy LLC dba
PMnow; Stafford, VA; Microscale Devices, LLC; Apex, NC; NaNotics, LLC;
Mill Valley, CA; Noblis, Inc.; Reston, VA; NOTA Laboratories, LLC; Ann
Arbor; MI; NovoBiotic Pharmaceuticals, LLC; Cambridge, MA; NuMat
Technologies, Inc.; Stokie, IL; NYU School of Medicine; New York; NY;
OCMS Bio, LLC; Wynnewood, PA; One Health Group, LLC; Chantilly, VA;
Partner Therapeutics, Inc.; Lexington, MA; Patricio Enterprises, Inc.;
Stafford, VA; Presco, Inc.; Woodbridge, CT; Puritan Medical Products;
Guilford, ME; Ridgeback Biotherapeutics LP; Miami, FL; Sanofi Pasteur
VaxDesign Corporation; Orlando, FL; Selva Therapeutics, Inc.; Del Mar,
CA; SINTX Technologies, Inc., Salt Lake City, UT; SitScape, Inc.;
Vienna, VA; Social & Scientific Systems, Inc.; Silver Spring, MD; SX2
Technologies, LLC; Port Washington, WI; Synexis BioDefense Systems,
LLC; Lenexa, KA; The Regents of the University of Colorado; Boulder,
CO; The Ultran Group, Inc.; State College, PA; The University of Texas
Medical Branch at Galveston; Galveston, TX; ThermoAnalytics, Calumet;
WI Trauma Insight, LLC; San Antonio, TX; Trustees of Boston University;
Boston, MA; University of Michigan; Ann Arbor, MI; Virginia Tech
Applied Research Corporation; Arlington, VA; Visionary Products, Inc.;
Draper, UT; ZabBio, Inc.; San Diego, CA have been added as parties to
this venture.
Terminal Horizon Operations and Resourcing, Inc.; St. Petersburg,
FL, has withdrawn as a party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MCDC intends to file additional
written notifications disclosing all changes in membership.
On November 13, 2015, MCDC filed its original notification pursuant
to Section 6(a) of the Act. The Department of Justice published a
notice in the Federal Register pursuant to Section 6(b) of the Act on
January 6, 2016 (81 FR 513).
The last notification was filed with the Department on January 16,
2020. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on February 4, 2020 (85 FR 6222).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2020-10739 Filed 5-18-20; 8:45 am]
BILLING CODE 4410-11-P